THE LYMPHOCYTE DYNAMICS PREDICTS THE BETTER RESPONSE FOR DASATINIB TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Yuho Najima, 100231

CLINICAL SIGNIFICANCE OF CO-EXPRESSION OF MYC AND BCL2 PROTEIN IN AGGRESSIVE B-CELL LYMPHOMAS TREATED WITH A SECOND LINE IMMUNOCHEMOTHERAPY.

EHA Library, Katsuhiro Miura, 100232

VON WILLEBRAND FACTOR DEFICIENCY CORRECTED BY LUNG TRANSPLANTATION.

EHA Library, Ana Lario, 100233

ABSOLUTE QUANTIFICATION OF EVI1 OVEREXPRESSION IN ACUTE MYELOID LEUKEMIA BY RQ-PCR ANALYSIS: A STUDY OF THE ALFA GROUP

EHA Library, Thomas Smol, 100234

OPTIMIZATION OF THERAPEUTIC DOSES OF RADOTINIB FOR CHRONIC MYELOID LEUKEMIA BASED ON EXPOSURE-RESPONSE RELATIONSHIP ANALYSES

EHA Library, Hayeon Noh, 100235

THE OUTCOMES OF HAPLOIDENTICAL HEMATOPOETIC STEM CELL TRANSPLANTATION PERFORMED WITH UNMANIPULATED DONOR STEM CELLS AND POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HIGH RISK CHILDREN

EHA Library, M. Akif Yesilipek, 100236

PROPHYLACTIC USE OF SORAFENIB IN PATIENTS WITH FLT3-ITD-POSITIVE ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qifa Liu, 100237

EXPRESSION OF TH17/TREGS AXIS ASSOCIATED REGULATORY FACTORS IN PATIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Qifa Liu, 100238

THE EBMT RISK SCORE CAN PREDICT THE OUTCOME AFTER ALLOGENEIC HEMATOPOIETC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AMONG EGYPTIAN PATIENTS

EHA Library, Samah Desoukey, 100239

SERUM LEVELS OF FMS-LIKE TYROSINE KINASE LIGAND IN MULTIPLE MYELOMA PATIENTS ARE CORRELATED WITH MARKERS OF TUMOR PROGRSSION

EHA Library, Michael Alexandrakis, 100241

HS-TROPONINE T RELATES WITH MYOCARDIAL IRON OVERLOAD IN TRANSFUSION DEPENDENT THALASSEMIC PATIENTS

EHA Library, Calogero Vetro, 100242

THE ARROVEN STUDY (MA25101): POST-AUTHORISATION OBSERVATIONAL SAFETY STUDY OF BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA AND SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Kim Linton, 100243

EXPRESSION OF SOXC CLUSTER AND MIR-17-92 POLYCISTRON IN MANTLE CELL LYMPHOMA PATIENTS.

EHA Library, Alejandro Roisman, 100244

PATIENTS’ PERCEPTIONS OF RECEIVING A DIAGNOSIS OF A HAEMATOLOGICAL MALIGNANCY, FOLLOWING THE SPIKES PROTOCOL

EHA Library, Lauren Dixon, 100245

FACTORS AFFECTING SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA WHO RECEIVED DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Fatih Kurnaz, 100246

WHICH GUIDELINES TO TRUST? CRITICAL APPRAISAL OF CLINICAL PRACTICE GUIDELINES FOR MANTLE CELL LYMPHOMA SHOWS HIGH VARIABILITY AMONG RECOMMENDATIONS.

EHA Library, Monia Marchetti, 100247

TREATMENT WITH LOW-DOSE CYTARABINE (LD-ARAC) IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA (AML): A SINGLE INSTITUTION EXPERIENCE

EHA Library, Maël Heiblig, 100248

HUMAN MYELOID INHIBITORY C-LECTIN (HMICL):A NOVEL ACUTE MYELOID LEUKEMIA MARKER

EHA Library, Eman Kandeel, 100249

ARTISAN PCR: HIGHLY RELIABLE IDENTIFICATION OF FULL-LENGTH B-CELL RECEPTOR SEQUENCES

EHA Library, Marvyn Koning, 100250

ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS OF PONATINIB AND ITS EFFECTS ON MACROMOLECULAR CHANGES IN IMATINIB-SENSITIVE AND –RESISTANT CHRONIC MYELOID LEUKEMIA (CML) CELL LINES: A MECHANISTIC APPROACH

EHA Library, Melis Kartal Yandim, 100251

ENDOSTEAL AND VASCULAR STRUCTURES OF BONE MARROW STROMA IN CLL

EHA Library, Natalya Semenova, 100252

ONE OUT OF FOUR TREATMENT-NAÏVE CLL PATIENTS IN TAIWAN CARRY TP53 MUTATIONS: CLINICAL AND PATHOGENETIC IMPLICATIONS

EHA Library, SHANG-JU WU, 100253

A PHASE IIA STUDY OF SINGLE-AGENT MOR208, AN FC-OPTIMIZED ANTI-CD19 ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA

EHA Library, Wojciech Jurczak, 100254

NELARABINE IN CHILDREN WITH REFRACTORY AND RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Natalia Myakova, 100255

RELATIVE DOSE INTENSITY OF CHEMOTHERAPY AND PREVENTION OF FEBRILE NEUTROPENIA WITH BIOSIMILAR FILGRASTIM: A MULTICENTRIC OBSERVATIONAL STUDY OF 633 LYMPHOID MALIGNANCY PATIENTS (THE ZOHÉ STUDY).

EHA Library, Philippe Rodon, 100256

MATURATION-ASSOCIATED IMMUNOPHENOTYPIC CLASSIFICATION OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS

EHA Library, Julia Almeida, 100257

CARBOPLATIN, ARACTYIN PLUS DEXAMETHASONE WITH OR WITHOUT RITUXIMAB (DHAC+/-R) IS A FEASIBLE AND EFFECTIVE TREATMENT FOR LYMPHOMA PATIENTS

EHA Library, Benoit Tessoulin, 100258

FACTOR V DEFICIENCY IN WEST OF ALGERIA : SINGLE CENTER EXPERIENCE

EHA Library, Amine Moueden, 100259

TOXICITY AND EFFICACY OF BENDAMUSTINE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND INDOLENT LOW GRADE NON-HODGKINS LYMPHOMA (INHL); A MULTI-CENTRE OBSERVATION OF REAL LIFE EXPERIENCE IN THE UK

EHA Library, Duncan Murray, 100260

INCIDENCE OF MALIGNANCY IN ADULT PATIENTS WITH AUTOIMMUNE THROMBOCYTOPENIC PURPURA: A 12 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Mahmoud Ayesh (Haj Yousef), 100261

ERYTHROCYTE-DERIVED MICROVESICLE RELEASE DURING EX-VIVO CARDIOPULMONARY BYPASS PROCEDURES

EHA Library, Rick Huisjes, 100262

CHEMOTHERAPY-INDUCED NEUROPATHY AMONG MULTIPLE MYELOMA PATIENTS AND THE INFLUENCE OF CHEMOTHERAPEUTIC AGENTS: RESULTS FROM THE POPULATION-BASED PROFILES STUDY.

EHA Library, Antoinetta Beijers, 100263

IMPACT OF NOVEL THERAPIES ON MULTIPLE MYELOMA SURVIVAL–CURRENT AND FUTURE OUTCOMES.

EHA Library, Amar Drawid, 100264

AN OBSERVATIONAL CLINICAL PRACTICE STUDY OF ROMIPLOSTIM IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA (ITP) – PLATON INTERIM RESULTS

EHA Library, Georgi Mihaylov, 100265

NILOTINIB IN JAPANESE PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) WITH SUBOPTIMAL MOLECULAR RESPONSE (MR) TO FRONTLINE IMATINIB: SENSOR FINAL 24-MO ANALYSIS AND BIM POLYMORPHISMS SUBSTUDY

EHA Library, Masafumi Taniwaki, 100266

CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III AND PRIMARY HEMOCHROMATOSIS; COEXISTENCE OF MUTATIONS IN KIF23 AND HFE.

EHA Library, Maria Liljeholm, 100267

CONCORDANCE BETWEEN CYTOLOGY AND FLOW CYTOMETRY IN THE DIAGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Isabel González-Gascón y Marín, 100268

SIL INDEX IS A SIMPLE AND OBJECTIVE PROGNOSTIC INDICATOR IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Naoto Tomita, 100269

IL-10/IL-17 DOUBLE-PRODUCING T CELLS: NEW IMMUNOSUPPRESSIVE INSIGHT IN ACUTE MYELOID LEUKEMIA

EHA Library, Silvia Carloni, 100270

THE RATIO OF LEUKOCYTE AND RED BLOOD CELL CLONES IN PATIENTS WITH AA/PNH AND THEIR CORRELATION WITH LDH LEVEL

EHA Library, Elene Shilova, 100271

A PROPOSAL OF CLASSIFICATION FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

EHA Library, Anna Gaya, 100272

UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL, DOSE-ESCALATION PHASE 1B/2 STUDY OF SINGLE-AGENT OPROZOMIB IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, INCLUDING WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, David Siegel, 100273

PREDICTIVE FACTORS TO ACHIEVE DEEP MOLECULAR RESPONSE AND LONG-TERM OUTCOMES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS. A SINGLE CENTER EXPERIENCE IN ARGENTINA.

EHA Library, Maria Jose Mela Osorio, 100274

A STUDY OF THE MARKERS OF THROMBIN GENERATION AND INFLAMMATION IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN A SUBSET OF PATIENTS SEEN AT A TERTIARY CARE CENTRE IN NORTH INDIA

EHA Library, Rishi Dhawan, 100275

SUSTAINED INFLAMATORY CYTOKINES IN NAÏVE GAUCHER DISEASE: A LINK WITH MULTIPLE MYELOMA?

EHA Library, Marcio Miguel Andrade Campos, 100276

PROSPECTIVE STUDY OF PLASMA BIOMARKERS ASSOCIATED WITH THE INFLAMMATORY RESPONSE IN TYPE 1 GAUCHER DISEASE PATIENTS TREATED DURING ONE YEAR WITH VELAGLUCERASE ALFA.

EHA Library, Marcio Andrade-Campos, 100277

OUTCOMES OF SPLENECTOMY IN NON-HODGKIN’S LYMPHOMAS COMPLICATED BY IMMUNE CYTOPENIAS

EHA Library, Yuriy Yevstakhevych, 100278

DETECTING EARLY RELAPSE IN MULTIPLE MYELOMA AFTER ASCT: USEFULNESS OF IMMUNEASSAYS.

EHA Library, Marcio Miguel Andrade Campos, 100279

SEVERE INFECTION IN ELDERLY PATIENTS TREATED WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE INTERGROUPE FRANCOPHONE DU MYÉLOME (IFM) 2009 01 PROTOCOL

EHA Library, Philippe Rodon, 100280

GRANULOCYTE COLONY-STIMULATING FACTOR INHIBITS CXCR4/SDF-1Α SIGNALING AND OVERCOMES STROMAL-MEDIATED DRUG RESISTANCE IN HL-60 CELL LINE

EHA Library, Hua Zhong, 100281

COMPARISON OF DIFFERENT COMORBIDITY INDICES FOR PREDICTING OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Friederike Hitz, 100282

GRANZYME B EXPRESSION IN T-REGULATORY CELLS ON DAY +14 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) IS A STRONG PREDICTOR OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD)

EHA Library, Mikhail Drokov, 100283

TUMOR GROWTH IS ASSOCIATED WITH INCREASED MCD VALUES AND TISSUE EXPRESSION OF ENDOGLIN IN MULTIPLE MYELOMA

EHA Library, Georgios Tsirakis, 100284

TREG CELLS IN CLL: DEFECTIVE FUNCTION AND HIGH CD39 EXPRESSION

EHA Library, Özgür Mehtap, 100285

HBV CLEARANCE IN HBSAG+ PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IS HERALDED BY GVHD OF LIVER

EHA Library, Tran-Der Tan, 100286

LONG-TERM OUTCOMES OF LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (RD) IN CHINESE PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): MM-024 EXTENDED ACCESS PROGRAM (EAP)

EHA Library, Zhen Cai, 100287

EVALUATION OF INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE 94 C>A, IVS2 + 21 A>C POLYMORPHYSMS IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH 6-MP AND PREDICTION OF ITS MYELOSUPPRESSIVE EFFECTS

EHA Library, Yousef Mortazavi, 100288

FLOW CYTOMETRY IMMUNOPHENOTYPING AND CYTOLOGICAL ANALYSES OF CSF: A COMPARISON OF PERFORMANCES FOR LYMPHOMATOUS CELL DETECTION

EHA Library, Myrto Costopoulos, 100289

BENCE JONES PROTEINURIA IN SMOLDERING MULTIPLE MYELOMA AS PREDICTOR MARKER OF PROGRESSION TO SYMPTOMATIC MULTIPLE MYELOMA

EHA Library, Veronica Gonzalez de la Calle, 100290

COOPERATIVE MUTATION STUDY IN KOREAN PATIENTS WITH MLL-REARRANGED ACUTE MYELOID LEUKEMIA USING TARGETED NEXT GENERATION SEQUENCING

EHA Library, So YoungKim, 100291

CLINICAL OUTCOMES OF AML PATIENTS TREATED WITH AZACITIDINE IN PORTUGAL: A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Antonio De Almeida, 100292

GENOME-WIDE DNA COPY NUMBER IMBALANCES ASSOCIATED WITH HIV POSITIVE PLASMABLASTIC LYMPHOMAS

EHA Library, Pascale Willem, 100293

CLINICAL FEATURES AND OUTCOMES IN PATIENTS WITH PRIMARY TESTICULAR LYMPHOMA

EHA Library, Yuki Nakajima, 100294

PLASMA CELLS NEGATIVE SELECTION TECHNIQUE IN SAMPLES OF PLASMA CELL DYSCRASIA PATIENTS.

EHA Library, Jose Antonio Perez-Simon, 100295

FRONTLINE INDUCTION THERAPY FOR MULTIPLE MYELOMA (MM) IN REAL-WORLD CLINICAL PRACTICE: THIRD INTERIM ANALYSIS OF THE MULTINATIONAL, OBSERVATIONAL EMMOS STUDY (NCT01241396)

EHA Library, Mohamad Mohty, 100296

CT IS SUPERIOR TO X-RAY IN DIAGNOSING OSTEOLYTIC LESIONS IN THE SPINE AND PELVIS: A PROSPECTIVE STUDY OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

EHA Library, Maja Hinge, 100297

INVOLVEMENT OF HISTONE ACETYLTRANSFERASES IN DEVELOPMENT OF ACUTE PROMYELOCYTIC LEUKEMIA AND RESPONSE TO DIFFERENTIATION-INDUCING COMPOUND

EHA Library, Yoshitaka Sunami, 100298

RECENT TIME TRENDS IN THE UPTAKE OF SPLENECTOMY IN ADULTS DIAGNOSED WITH CHRONIC IMMUNE THROMBOCYTOPENIA: A NATIONWIDE HISTORICAL COHORT STUDY IN DENMARK, 1996-2012

EHA Library, Sally Wetten, 100299

CLINICAL OUTCOMES OF ACUTE ERYTHROLEUKEMIA TREATED WITH AZACITIDINE: A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Antonio De Almeida, 100300

CD47 AGONIST PEPTIDES INDUCE PROGRAMMED CELL DEATH IN REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS VIA PLCG1 ACTIVATION

EHA Library, Hélène Merle-Béral, 100301

HIGHLY SUSPECTED LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WITHOUT PATHOLOGICAL EVIDENCE: PET-CT FEATURES AND TREATMENT OUTCOME

EHA Library, Hongxia Qiu, 100302

EFFICACY AND TOXICITY OF FLUDARABINE BASED INDUCTION REGIMENS IN ACUTE MYELOID LEUKEMIA PATIENTS YOUNGER THAN 65 YRS.

EHA Library, Anna CANDONI, 100303

DAUNORUBICIN INDUCED EARLY CARDIAC DYSFUNCTION IN ACUTE LYMPHOBLASTIC LEUKEMIA- A PROSPECTIVE STUDY

EHA Library, Mukul Aggarwal, 100304

COMPOUND FACTOR V AND FACTOR VIII DEFICIENCY IN ALGERIA.

EHA Library, BENLALDJ DRISS, 100305

TRIM32 E3 LIGASE AS A TARGET IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Cliona , 100306

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NON-MALIGNANT HEMATOLOGICAL DISORDERS

EHA Library, Yasser Elnahass, 100307

RESPONSE AND EARLY RELAPSE ASSESSMENT IN MULTIPLE MYELOMA TREATED WITH BORTEZOMIB: ROLE OF HEAVY/LIGHT-CHAIN IMMUNEASSAY

EHA Library, Marcio Miguel Andrade Campos, 100308

SCA1+ MESENCHYMAL STROMAL CELLS INHIBIT GRAFT-VERSUS-HOST DISEASE IN MICE AFTER BONE MARROW TRANSPLANTATION

EHA Library, Fan Wen, 100309

PIVOTAL BIOMARKER ALTERATIONS IN CYTARABINE-RESISTANT ACUTE MYELOID LEUKEMIA CELL LINES

EHA Library, Jeng-Wei Lu, 100310

ACTIVATED STAT5 AS NOVEL STEM CELL TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)

EHA Library, Emir Hadzijusufovic, 100311

CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOMES OF PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA (T-MDS/AML)

EHA Library, Su Wai Maung, 100313

INTRAPLEURAL RITUXIMAB FOR THE TREATMENT OF MALIGNANT PLEURAL EFFUSION DUE TO CD20-POSITIVE LYMPHOMA

EHA Library, Man Fai Law, 100314

CARDIOVASCULAR (CV)-RELATED HOSPITALIZATION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Ron Paquette, 100315

INITIAL EVALUATION OF NOVEL DUAL PIM/PI3K AND TRIPLE PIM/PI3K/MTOR INHIBITORS IN MULTIPLE MYELOMA

EHA Library, Mairead Reidy, 100316

A CASE OF INDOLENT SYSTEMIC MASTOCYTOSIS IN A GIRL TREATED WITH INTERFERON

EHA Library, Yasemin Altuner Torun, 100317

ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: 15-YEAR EXPERIENCE AT A SINGLE CENTER.

EHA Library, Ana Lario, 100318

GENE AND PROTEIN EXPRESSION ANALYSES OF THE MTOR SIGNALING PATHWAY IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Olivera Mitrovic, 100319

THE EFFICACY OF THE 5-AZACITIDINE IN THE THERAPY-RELATED MYELOID NEOPLASIA: A RETROSPECTIVE MULTICENTRIC EXPERIENCE.

EHA Library, Marta Riva, 100320

MAJOR CARDIOVASCULAR EVENTS AND COMORBIDITIES IN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA

EHA Library, Neil Minton, 100321

DOES NEUTROPENIA AFFECTS HERPES VIRUS REACTIVATION IN CRITICALLY ILL PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND PNEUMONIA?

EHA Library, Dmitry Tikhomirov, 100322

MICRO-RNAS ASSOCIATED WITH PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DO NOT IMPACT OVERALL SURVIVAL IN PATIENTS WHO RECEIVE NONMYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANT (NMAT)

EHA Library, Issa Khouri, 100323

CHARACTERIZATION OF THE DNA-DAMAGE RESPONSE DOWNSTREAM OF B-CELL RECEPTOR SIGNALING IN CLL.

EHA Library, Nadine Nickel, 100324

SWITCHING TO NILOTINIB IS ASSOCIATED WITH DEEPER MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA CHRONIC PHASE WITH MAJOR MOLECULAR RESPONSES ON IMATINIB; STAT1 TRIAL IN JAPAN

EHA Library, Naoto Takahashi, 100325

BRENTUXIMAB VEDOTIN (BV) AN EFFECTIVE TREATMENT FOR TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL)

EHA Library, Simonetta Viviani, 100326

SIGNIFICANCE OF ANEMIA IN PATIENTS WITH CML AT DIAGNOSIS AND DURING THE TREATMENT WITH IMATINIB OUTSIDE THE CLINICAL TRIALS: CAMELIA REGISTRY EXPERIENCE

EHA Library, Edgar Faber, 100327

CLINICAL CHARACTERISTICS OF POLYCYTHEMIA VERA PATIENTS, RECEIVING DIFFERENT TYPES OF THERAPY.

EHA Library, Dzhariiat Shikhbabaeva, 100328

ACQUIRED UNIPARENTAL DISOMY OF CHROMOSOME 14 IN MYELOID MALIGNANCIES TARGETS THE IMPRINTED MEG3-DLK1 LOCUS

EHA Library, Andrew Chase, 100329

CHARACTERIZATION OF 6 HEMOGLOBINOPATHIES OCCURRING WITH CYANOSIS AND/OR LOWERING THE OXIGEN SATURATION

EHA Library, Williana Torres, 100330

NARROWBAND ULTRAVIOLET-B PHOTOTHERAPY IN A PEDIATRIC PATIENT WITH CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Ibrahim Eker, 100331

A SCORING SYSTEM BASED ON LEUKOCYTE ALKALINE PHOSPHATASE ACTIVITY AND PERIPHERAL GRANULOCYTE PRECURSOR PERCENTAGE PREDICTS JAK2 V617F MUTATION IN PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Rosangela Invernizzi, 100332